Jounce Therapeutics, Inc. is a clinical stage immunotherapy company dedicated to transforming the treatment of cancer by developing therapies that enable the immune system to attack tumors and provide long‑lasting benefits to patients. Through the use of its Translational Science Platform, Jounce first focuses on specific cell types within tumors to prioritize targets, and then identifies related biomarkers designed to match the right therapy to the right patient. Jounce’s lead product candidate, JTX-2011, is a monoclonal antibody that binds to and activates ICOS and is currently in a Phase 1/2 trial. For more information, please visit http://jouncetx.com/
We have many career opportunities at Jounce and are looking for exceptional individuals who share our passion and perseverance for developing highly durable cancer immunotherapies that can dramatically impact and improve patients’ lives.
Summary: The Head of Clinical Pharmacology will have a pivotal role in providing strategic clinical pharmacology guidance on our drug development, including modeling to support FIH dose, and development and execution of plans to analyze PK, ADA, drug interaction studies, pharmacodynamics, and population PK. The candidate will possess strong writing capabilities, be able to contribute to non- clinical and clinical protocols, statistical analysis plans, clinical study reports, abstracts and presentations for scientific and medical meetings, and briefing documents for regulatory agencies from INDs through BLAs. The candidate will bring extensive experience in oncology, quantitative pharmacology (both clinical and non-clinical experience), and work cross-functionally research and clinical teams to drive our programs to success.
To apply, please visit https://careers-jouncetx.icims.com/